Stoke Therapeutics, Inc. STOK Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $184.42M+405% | $36.56M+316% | $8.78M-29.2% | $12.4M— | ||
| $137.92M+54.7% | $89.13M+8.4% | $82.23M+5.6% | $77.84M+43.7% | ||
| $67.09M— | —— | —— | —— | ||
| $205.01M+48.6% | $137.93M+11.6% | $123.55M+5.8% | $116.76M+35.7% | ||
| $205.01M+48.6% | $137.93M+11.6% | $123.55M+5.8% | $116.76M+35.7% | ||
| -$20.59M+79.7% | -$101.37M+11.7% | -$114.77M-10.0% | -$104.36M-21.3% | ||
| -11.2%+266pp | -277.3%+1,030pp | -1,307%-466pp | -841.3%— | ||
| $13.76M+8.9% | $12.64M+27.5% | $9.91M+217% | $3.12M+2,502% | ||
| $13.71M+10.6% | $12.39M+23.0% | $10.07M+206% | $3.29M+1,165% | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| -$6.89M+92.3% | -$88.98M+15.0% | -$104.7M-3.6% | -$101.07M-17.8% | ||
| -3.7%+240pp | -243.4%+949pp | -1,192.3%-378pp | -814.8%— | ||
| -$0.12+92.8% | -$1.67+29.5% | -$2.37+8.8% | -$2.60+11.6% | ||
| -$0.10+94.0% | -$1.67+29.5% | -$2.37+8.8% | -$2.60-11.1% | ||
| 235.6M+10.9% | 212.4M+21.4% | 175M+12.9% | 155M+5.6% | ||
| 234M+10.2% | 212.4M+21.4% | 175M+12.9% | 155M— | ||
| $13.76M+8.9% | $12.64M+27.5% | $9.91M+217% | $3.12M+2,502% | ||
| -$6.19M+93.1% | -$89.11M+13.9% | -$103.55M-1.4% | -$102.07M-18.7% | ||
| $694K+646% | -$127K-111% | $1.15M— | —— | ||
| $694K+646% | -$127K-111% | $1.15M— | —— | ||
| -$51K— | —— | $165K-1.8% | $168K+20.0% | ||
| -$20.59M+79.7% | -$101.37M+11.7% | -$114.77M-10.0% | -$104.36M-21.3% | ||
| -$18.82M+81.0% | -$99.19M+11.7% | -$112.3M-9.2% | -$102.81M-20.8% | ||
| -$18.82M+81.0% | -$99.19M+11.7% | -$112.3M-9.2% | -$102.81M-20.8% | ||
| -10.2%+261pp | -271.4%+1,008pp | -1,278.9%-450pp | -828.9%— | ||
| -$20.59M+79.7% | -$101.37M+11.7% | -$114.77M-10.0% | -$104.36M-21.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Stoke Therapeutics, Inc.'s income statement data come from?
- Every line is extracted from Stoke Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.